American Century Companies’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
Other funds holding CABA
BCLSI
CAM
WP
American Century Companies's CABA Position: Q2 2026 in Review
American Century Companies reduced its Cabaletta Bio (CABA) stake by 91% in Q2 2026, selling an estimated $323K and leaving 10,103 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2875.
American Century Companies first reported a position in CABA in Q2 2023 and has held it in 5 quarters since. The position peaked at $291K in Q1 2026. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.
- American Century Companies held 10,103 shares of Cabaletta Bio worth $31.4K as of Q2 2026.
- American Century Companies sold 98,216 Cabaletta Bio shares in Q2 2026, an estimated $323K.
- Cabaletta Bio made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2875 holding.
- American Century Companies first reported a position in Cabaletta Bio in Q2 2023 and has held it in 5 quarters since.
- American Century Companies's Cabaletta Bio position peaked at $291K in Q1 2026.
- 139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.